IDXX:NASDAQ
IDEXX Laboratories Inc
$518.00
arrow_upward
+0.95%(+4.86) 1D
$518.00
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IDXX...
Open
$513.67
High
$522.02
Low
$513.10
Mkt. cap
40.81B
Avg. vol.
505.84K
Volume
466.78K
P/E ratio
36.41
52-wk high
$769.98
52-wk low
$500.61
EPS
$14.23
Beta
1.55
Shares outstanding
78.78M
No. of employees
11K
Open
$513.67
High
$522.02
Low
$513.10
Mkt. cap
40.81B
Avg. vol.
505.84K
Volume
466.78K
P/E ratio
36.41
52-wk high
$769.98
52-wk low
$500.61
EPS
$14.23
Beta
1.55
Shares outstanding
78.78M
No. of employees
11K
News stories
From web sources and news partners
Stock Traders Daily
·
17 hours ago
(IDXX) Movement Within Algorithmic Entry Frameworks
Yahoo Finance
·
3 weeks ago
IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics
Profile
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
About IDEXX Laboratories Inc
CEOJay Mazelsky
Employees11K
FoundedDec 19, 1983
HeadquartersWestbrook, Maine, United States
SectorMedical device
Websiteidexx.com